Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
TransUnion beats expectations, raises full-year outlook and provides Q4 guidance, driven by robust demand and improving profitability.
MLB announces National League Silver Slugger finalists, highlighting standout offensive performances from players across the league.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
TransUnion beats expectations, raises full-year outlook and provides Q4 guidance, driven by robust demand and improving profitability.
MLB announces National League Silver Slugger finalists, highlighting standout offensive performances from players across the league.